Skip to main content

Publication, Part of

National Diabetes Audit: Non-Diabetic Hyperglycaemia, 2019-2020, Diabetes Prevention Programme

Audit, Survey, Other reports and statistics


The NHS Diabetes Prevention Programme (NHS DPP) is a joint commitment from NHS England, Public Health England and Diabetes UK to deliver, at scale, evidence based behavioural interventions that can prevent or delay the onset of Type 2 diabetes in adults identified as having non-diabetic hyperglycaemia.

The DPP report uses data collected alongside the National Diabetes Audit (NDA) for the period January 2019 to March 2020 and data from providers of the Diabetes Prevention Programme relating to referrals up to March 2020 inclusive.

This report is for England only.

What is Non-diabetic hyperglycaemia (NDH)?

Non-diabetic hyperglycaemia refers to blood glucose levels that are above normal but not in the diabetic range (HbA1c 42-47 mmol/mol (6.0-6.4%) or fasting plasma glucose 5.5-6.9 mmol/l).

Diagnoses of NDH

2.1 million people in England are recorded as having non-diabetic hyperglycaemia.

Monitoring people with NDH

People with NDH have usually had a recent blood glucose test (78%) and Body Mass Index (BMI) recording (64%).

Last edited: 7 July 2021 4:06 pm